The first of 396 patients has been enrolled into the PROTECT study with the aim of setting new standards for the clinical use of proton radiotherapy in esophageal cancer.

19 public and industry partners across Europe are joining forces in an ambitious collaborative clinical research project with the aim of setting new standards for the clinical use of proton radiotherapy.